Maryam Lustberg, MD, MPH
Chief of Breast Medical Oncology at Yale Cancer Center
Medical School
University of Maryland
Residency
Internal Medicine, University of Maryland
Fellowship(s)
Medical Oncology and Breast Medical Oncology, The Ohio State University
Area of Expertise
- Breast Cancer Treatment and Research
- Cancer Survivorship
- Symptom Management and Toxicity
- Blood-based Biomarkers
- Clinical Trials in Breast Cancer
Years of Experience
Over 15 years
Certifications & Licensure
- Board Certified in Medical Oncology (American Board of Internal Medicine, 2010)
- Board Certified in Internal Medicine (American Board of Internal Medicine, 2006)
Biography
Dr. Maryam Lustberg is a distinguished physician-scientist specializing in breast cancer care and research. As the Director of the Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center, and Chief of Breast Medical Oncology, she leads comprehensive breast cancer programs and oversees a diverse portfolio of clinical trials.
Dr. Lustberg’s research focuses on improving long-term outcomes for breast cancer patients, particularly in the areas of treatment-related side effects and survivorship. She is actively investigating novel blood-based biomarkers to identify recurrence and treatment toxicity earlier. Her work is supported by grants from the National Cancer Institute and she collaborates extensively with researchers worldwide.
Nationally recognized for her expertise, Dr. Lustberg serves on several committees for the American Society of Clinical Oncology (ASCO) and is the President-Elect of the Multinational Association of Supportive Care in Cancer (MASCC). She is also an Associate Editor for the Journal of Cancer Survivorship.
Dr. Lustberg completed her medical degree and residency at the University of Maryland, followed by fellowships in medical oncology and breast medical oncology at The Ohio State University. She also holds a Master’s in Public Health from The Ohio State University, focusing on clinical investigation and translational research in breast cancer.
Awards & Honors
- Named to Forbes list of top breast medical oncologists in the nation
- Castle Connolly’s “Regional Top Doctors” list
- Castle Connolly’s “Exceptional Women in Medicine” for 2020
- Best Teacher Award by Hematology Oncology Fellows
- Shining Star Award for Medical Student Mentorship
- ASCO Young Investigator Award
- Selected for participation in the American Society of Clinical Oncology (ASCO) Leadership Development Program
Selected Publications
- Kang L, Kadan-Lottick N, Rotatori J, et al. Patterns of Physical Therapy Referral and Subsequent Attendance Among Childhood Cancer Survivors with Chemotherapy-Induced Peripheral Neuropathy at a Regional Childhood Cancer Survivorship Clinic. Seminars In Oncology Nursing 2024, 151716.
- Melink Z, Lustberg M, Schnell P, et al. Effect of minocycline on changes in affective behaviors, cognitive function, and inflammation in breast cancer survivors undergoing chemotherapy: a pilot randomized controlled trial. Breast Cancer Research And Treatment 2024, 1-13.
- Orchard T, Winschel T, Weinhold K, et al. Adherence to a MIND Diet Pattern Is Associated With Better Cognitive Function and Less Peripheral Inflammation in Breast Cancer Survivors. Current Developments In Nutrition 2024, 8: 103175.
featured Articles
Mitigating Long-term and Delayed Adverse Events in Cancer Treatment
We explore the common long-term and delayed adverse events associated with cancer treatment.
LGBTQ+ Breast Cancer Journeys: Overcoming Unique Hurdles
LGBTQ+ individuals often encounter unique obstacles when navigating breast cancer.
Integrated Therapies in Breast Cancer Care
Explore acupuncture, meditation & more for pain management & well-being.
Featured Interview
Empowering Patients: Understanding Breast Cancer Diagnosis and Care
Testimonial
Latest News & Resources
News
Patient Resources
MEET OUR EXPERT MEDICAL TEAM
Explore the expertise of our medical advisors, who are dedicated to advancing breast cancer awareness, treatment, and support. Connect with our team and discover how their guidance contributes to the resources and insights available within our breast cancer support groups.
